June 9, 2020 / 10:49 AM / 25 days ago

BRIEF-Mallinckrodt Completes Rolling Submission Of Biologics License For Stratagraft Regenerative Skin Tissue To FDA

June 9 (Reuters) - Mallinckrodt Plc:

* MALLINCKRODT COMPLETES ROLLING SUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR STRATAGRAFT® REGENERATIVE SKIN TISSUE TO U.S. FOOD AND DRUG ADMINISTRATION

* MALLINCKRODT PLC - STRATAGRAFT SKIN TISSUE IS IN DEVELOPMENT AS POTENTIAL NEW TREATMENT OPTION FOR PATIENTS WITH DEEP PARTIAL-THICKNESS THERMAL BURNS

* MALLINCKRODT PLC - STRATAGRAFT SKIN TISSUE IS AN INVESTIGATIONAL PRODUCT, AND ITS SAFETY AND EFFECTIVENESS HAVE NOT YET BEEN ESTABLISHED BY FDA. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below